Articles
no_image no_image no_image no_image no_image no_image no_image no_image
Topics
All | Vitamin & Nutrition | COVID-19 | General Information | Cancer | Cardiology
Stem Cell
Wound Care
Vaccinology
Radiology
Obstetry and Gynecology
Family Medicine
Anesthesiology
Epidemiology
COVID-19
Cancer
Cardiology
Pediatric
Clinical Procedure
Common Diseases
Dental And Oral Health
Dermathology And Aesthetic
Drug
Endocrinology
Eyes
Female
Gastroenterology
General Information
Geriatry
Hematology
Hepatology
Allergy & Immunology
Infection Disease
Inflammation
Male
Mental Health
Mouth Ear Nose
Nephrology
Neurology
Pain
Pathology
Pulmonology
Skeletal & Muscle
Surgery & Recovery
Urology
Vitamin & Nutrition
SPECIAL COVERAGE Featured Article
featured_img
Osimertinib Plus Chemotherapy: Better Survival in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
by dr. Johan Indra Lukito | 14 January 2026
EGFR (epidermal growth factor receptor)-mutated advanced non-small cell lung cancer (NSCLC) is a subtype of lung cancer caused by changes in the EGFR gene that persistently activate cell growth signals. The FLAURA2 clinical trial was conducted to determine whether combining platinum-pemetrexed chemotherapy with osimertinib, a third-generation EGFR-TKI, could improve outcomes for patients with previously untreated EGFR-mutated advanced NSCLC. This clinical trial compared the efficacy and safety of the combination regimen to osimertinib monotherapy.
CDK Awards 2026
by dr. Dita Arccinirmala | 13 January 2026
e2b7c65f4d4facc3eeeb566d898cd405.jpeg
OnabotulinumtoxinA: Effective for Reducing Platysma Prominence
by dr. Della Sulamita | 12 January 2026
e1141894d4a9f74eb1e7a6ec45394381.jpg
Latest Articles